Clinical Study of hUC-MSCs Treating Decompensated Liver Cirrhosis With HBV

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 8, 2019

Primary Completion Date

July 1, 2022

Study Completion Date

December 31, 2022

Conditions
HBV
Interventions
BIOLOGICAL

hUCMSCs

Human umbilical cord mesenchymal stem cell preparation, 100ml/ bag, containing 2.5×107 cells, 5.0×107 cells, 1.0 x 108 cells

Trial Locations (1)

430000

Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors
lead

Zhongnan Hospital

OTHER

NCT05442437 - Clinical Study of hUC-MSCs Treating Decompensated Liver Cirrhosis With HBV | Biotech Hunter | Biotech Hunter